Bilcare Limited has informed the Exchange about the Outcome of Board meeting held on March 30, 2026.
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare Limited's board met on March 30, 2026, and reported three developments. First, on March 23, 2026, the company redeemed 31.5 lakh (0.1% non-cumulative, non-participating redeemable) preference shares of Caprihans India Limited held by it, worth Rs. 3.15 crore at Rs. 10 per share. Second, Bilcare converted 12.9 lakh convertible warrants (originally issued at Rs. 200 each) into equity shares of Caprihans India Limited across four allotments between March 20 and March 25, 2026, raising its stake in Caprihans from 55.99% to 59.56% (94.78 lakh shares). Third, the voluntary liquidation of its UK-based wholly-owned subsidiary Bilcare GCS Limited was completed on March 18, 2026, with liquidation proceeds of GBP 195,781.83 still pending credit to Bilcare's account.
These are routine investment housekeeping and group restructuring actions rather than value-accretive events for shareholders. The increased stake in Caprihans slightly deepens Bilcare's investment exposure, and the closure of a tiny non-material UK subsidiary simplifies the group, but the amounts involved are small (the UK unit contributed just 0.02% of consolidated turnover) and unlikely to move the stock meaningfully.